Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. (2015)

First Author: White MT
Attributed to:  MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(15)00239-x

PubMed Identifier: 26342424

Publication URI: http://europepmc.org/abstract/MED/26342424

Type: Journal Article/Review

Volume: 15

Parent Publication: The Lancet. Infectious diseases

Issue: 12

ISSN: 1473-3099